Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
MAFLD, patient-centred care, and APASL
Hepatology International, Volume 16, No. 5, Year 2022
Notification
URL copied to clipboard!
Description
Asian–Pacific nations are home to more than half the world’s population and similar to other global super regions, metabolic dysfunction associated fatty liver disease (MAFLD) is the principal cause for chronic liver disease. To address the challenges ahead for tackling the disease at-scale, the Asian Pacific Association for the Study of the Liver (APASL) was the first pan-national society to endorse and lead the process for redefining the disease and adopting the more appropriate term “MAFLD” with its accompanying set of positive diagnostic criteria. As with this initiative, APASL and Hepatology International will continue to strive to lead the field and work with sister societies towards full adoption of MAFLD. This will advance the science and practice of Hepatology and help incorporate MAFLD within multidisciplinary care teams. Ultimately, it will lead to more cogent clinical trials built on innovative design platforms that include patients with any disease related to metabolic dysfunction. For our patients, an outcome of these endeavours will be the provision of holistic person-centred care for this disease that is so common in our region. © 2022, Asian Pacific Association for the Study of the Liver.
Authors & Co-Authors
Sarin, Shiv Kumar
India, New Delhi
Institute of Liver and Biliary Sciences
Eslam, Mohammed
Australia, Parramatta
The Westmead Institute for Medical Research
Fan, Jiangao
China, Shanghai
Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
George, Jacob
Australia, Parramatta
The Westmead Institute for Medical Research
Omata, Masao
Japan, Kofu
Yamanashi Prefectural Central Hospital
Japan, Tokyo
The University of Tokyo
Statistics
Citations: 5
Authors: 5
Affiliations: 6
Identifiers
Doi:
10.1007/s12072-022-10408-6
ISSN:
19360533
Research Areas
Health System And Policy
Noncommunicable Diseases
Study Design
Cross Sectional Study